ID ERR1_CANLF Reviewed; 422 AA. AC Q6QMY5; DT 10-JUL-2007, integrated into UniProtKB/Swiss-Prot. DT 05-JUL-2004, sequence version 1. DT 27-MAR-2024, entry version 121. DE RecName: Full=Steroid hormone receptor ERR1; DE AltName: Full=Estrogen-related receptor alpha; DE Short=ERR-alpha; DE AltName: Full=Nuclear receptor subfamily 3 group B member 1; GN Name=ESRRA; Synonyms=NR3B1; OS Canis lupus familiaris (Dog) (Canis familiaris). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis. OX NCBI_TaxID=9615; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Lu P., Colitz C.; RT "Dog estrogen related receptor alpha (Estrra) mRNA."; RL Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Binds to an ERR-alpha response element (ERRE) containing a CC single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium- CC chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and CC may act as an important regulator of MCAD promoter. May function as a CC modulator of the estrogen signaling pathway in the uterus. Induces the CC expression of PERM1 in the skeletal muscle (By similarity). CC {ECO:0000250}. CC -!- SUBUNIT: Binds DNA as a monomer or a homodimer. Interacts (via the AF2 CC domain) with coactivator PPARGC1A (via the L3 motif); the interaction CC greatly enhances transcriptional activity of genes involved in energy CC metabolism. Interacts with PIAS4; the interaction enhances sumoylation. CC Interacts with MAPK15; promotes re-localization of ESRRA to the CC cytoplasm through a XPO1-dependent mechanism then inhibits ESRRA CC transcriptional activity. {ECO:0000250|UniProtKB:P11474}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P11474, CC ECO:0000255|PROSITE-ProRule:PRU00407}. Cytoplasm CC {ECO:0000250|UniProtKB:P11474}. Note=Co-localizes to the cytoplasm only CC in presence of MAPK15. {ECO:0000250|UniProtKB:P11474}. CC -!- PTM: Phosphorylation on Ser-19 enhances sumoylation on Lys-14 CC increasing repression of transcriptional activity. {ECO:0000250}. CC -!- PTM: Sumoylated with SUMO2. Main site is Lys-14 which is enhanced by CC phosphorylation on Ser-19, cofactor activation, and by interaction with CC PIAS4. Sumoylation enhances repression of transcriptional activity, but CC has no effect on subcellular location nor on DNA binding (By CC similarity). {ECO:0000250}. CC -!- PTM: Reversibly acetylated. Acetylation by PCAF/KAT2 at Lys-129, Lys- CC 138, Lys-160 and Lys-162 and PCAF/KAT2 decreases transcriptional CC activity probably by inhibiting DNA-binding activity; deacetylation CC involves SIRT1 and HDAC8 and increases DNA-binding (By similarity). CC {ECO:0000250}. CC -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3 CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY533243; AAS20260.1; -; mRNA. DR RefSeq; NP_001002936.1; NM_001002936.1. DR AlphaFoldDB; Q6QMY5; -. DR SMR; Q6QMY5; -. DR STRING; 9615.ENSCAFP00000021334; -. DR PaxDb; 9612-ENSCAFP00000021334; -. DR GeneID; 403169; -. DR KEGG; cfa:403169; -. DR CTD; 2101; -. DR eggNOG; KOG3575; Eukaryota. DR InParanoid; Q6QMY5; -. DR OrthoDB; 5387678at2759; -. DR Proteomes; UP000002254; Unplaced. DR Proteomes; UP000694429; Unplaced. DR Proteomes; UP000694542; Unplaced. DR Proteomes; UP000805418; Unplaced. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB. DR GO; GO:0034056; F:estrogen response element binding; IBA:GO_Central. DR GO; GO:0004879; F:nuclear receptor activity; IBA:GO_Central. DR GO; GO:0003707; F:nuclear steroid receptor activity; IEA:InterPro. DR GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB. DR GO; GO:0005496; F:steroid binding; IEA:InterPro. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IBA:GO_Central. DR GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR CDD; cd07170; NR_DBD_ERR; 1. DR CDD; cd06946; NR_LBD_ERR; 1. DR Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1. DR Gene3D; 1.10.565.10; Retinoid X Receptor; 1. DR InterPro; IPR024178; Est_rcpt/est-rel_rcp. DR InterPro; IPR035500; NHR-like_dom_sf. DR InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd. DR InterPro; IPR001723; Nuclear_hrmn_rcpt. DR InterPro; IPR027289; Oest-rel_rcp. DR InterPro; IPR001628; Znf_hrmn_rcpt. DR InterPro; IPR013088; Znf_NHR/GATA. DR PANTHER; PTHR48092; KNIRPS-RELATED PROTEIN-RELATED; 1. DR PANTHER; PTHR48092:SF15; STEROID HORMONE RECEPTOR ERR1; 1. DR Pfam; PF00104; Hormone_recep; 1. DR Pfam; PF00105; zf-C4; 1. DR PIRSF; PIRSF002527; ER-like_NR; 1. DR PIRSF; PIRSF500939; ERR1-2-3; 1. DR PRINTS; PR00398; STRDHORMONER. DR PRINTS; PR00047; STROIDFINGER. DR SMART; SM00430; HOLI; 1. DR SMART; SM00399; ZnF_C4; 1. DR SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1. DR SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1. DR PROSITE; PS51843; NR_LBD; 1. DR PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1. DR PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1. PE 2: Evidence at transcript level; KW Acetylation; Cytoplasm; DNA-binding; Isopeptide bond; Metal-binding; KW Nucleus; Phosphoprotein; Receptor; Reference proteome; Transcription; KW Transcription regulation; Ubl conjugation; Zinc; Zinc-finger. FT CHAIN 1..422 FT /note="Steroid hormone receptor ERR1" FT /id="PRO_0000295231" FT DOMAIN 192..420 FT /note="NR LBD" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01189" FT DNA_BIND 76..151 FT /note="Nuclear receptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00407" FT ZN_FING 79..99 FT /note="NR C4-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00407" FT ZN_FING 115..134 FT /note="NR C4-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00407" FT REGION 1..67 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 19 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11474" FT MOD_RES 22 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11474" FT MOD_RES 129 FT /note="N6-acetyllysine; by PCAF/KAT2B" FT /evidence="ECO:0000250|UniProtKB:P11474" FT MOD_RES 138 FT /note="N6-acetyllysine; by PCAF/KAT2B" FT /evidence="ECO:0000250|UniProtKB:P11474" FT MOD_RES 160 FT /note="N6-acetyllysine; by PCAF/KAT2B" FT /evidence="ECO:0000250|UniProtKB:P11474" FT MOD_RES 162 FT /note="N6-acetyllysine; by PCAF/KAT2B" FT /evidence="ECO:0000250|UniProtKB:P11474" FT CROSSLNK 189 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:P11474" FT CROSSLNK 402 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:P11474" SQ SEQUENCE 422 AA; 45457 MW; 2739152CA0B355F4 CRC64; MSSQVVGIEP LYIKAEPASP DSPKGSSETE TEPPVALAPG PAPTRCLPGH KEEEDGEGAG PGEQGGGKLV LSSLPKRLCL VCGDVASGYH YGVASCEACK AFFKRTIQGS IEYSCPASNE CEITKRRRKA CQACRFTKCL RVGMLKEGVR LDRVRGGRQK YKRRPEVDPL PFPGSFPAGP LAVAGGPRKT APVNALVSHL LVVEPEKLYA MPDPAGPDGH LPAVATLCDL FDREIVVTIS WAKSIPGFSS LSLSDQMSVL QSVWMEVLVL GVAQRSLPLQ DELAFAEDLV LDEEGARAAG LGELGAVLLQ LVRRLQALRL EREEYVLLKA LALANSDSVH IEDAEAVEQL REALHEALLE YEAGRAGPGG GAERRRAGRL LLTLPLLRQT AGKVLAHFYG VKLEGKVPMH KLFLEMLEAM MD //